These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6354421)

  • 21. [Randomized melanoma study of perfusion of the extremities. Results of treatment 2 1/2 years after premature discontinuation].
    Ghussen F; Krüger I; Groth W; Stützer H
    Chirurg; 1986 Oct; 57(10):619-23. PubMed ID: 3539548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma.
    Ghussen F; Krüger I; Groth W; Stützer H
    Cancer; 1988 Feb; 61(4):654-9. PubMed ID: 3276384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of malignant melanoma of the limbs combined with thermochemotherapy under extracorporeal circulation].
    Truchetet F; Grosshans E; Kretz JG; Bartier JC; Laplanche G
    Ann Dermatol Venereol; 1988; 115(5):573-85. PubMed ID: 3195954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities--long-term follow-up of a randomised trial.
    Olofsson Bagge R; Mattsson J; Hafström L
    Int J Hyperthermia; 2014 Aug; 30(5):295-8. PubMed ID: 25144818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Free-flap evolution after hyperthermic regional chemotherapy in the isolated limb for malignant melanoma.
    Goldschmidt D; Van Geertruyden J; de Fontaine S
    J Reconstr Microsurg; 1998 Aug; 14(6):397-9. PubMed ID: 9734842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion.
    Martijn H; Oldhoff J; Oosterhuis JW; Koops HS
    Cancer; 1983 Oct; 52(8):1526-34. PubMed ID: 6616412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
    Ghussen F; Groth W; Nagel K
    Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater.
    Franklin HR; Schraffordt Koops H; Oldhoff J; Czarnetzki BM; Macher E; Kroon BB; Welvaart K; van der Velden JW; van Dijk E; van der Esch EP
    J Clin Oncol; 1988 Apr; 6(4):701-8. PubMed ID: 3357008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic isolation-perfusion as the primary therapy for invasive malignant melanoma of the limbs.
    McBride CM; Sugarbaker EV; Hickey RC
    Ann Surg; 1975 Sep; 182(3):316-24. PubMed ID: 1164059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors influencing the survival of patients with regional melanoma of the extremity treated by perfusion.
    Sutherland CM; Mather FJ; Krementz ET
    Surg Gynecol Obstet; 1987 Feb; 164(2):111-8. PubMed ID: 3810424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
    Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
    Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
    Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
    J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival and regional disease control after isolation-perfusion for invasive stage I melanoma of the extremities.
    Sugarbaker EV; McBride CM
    Cancer; 1976 Jan; 37(1):188-98. PubMed ID: 1247954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
    Kettelhack C; Hohenberger P; Schlag PM
    Dtsch Med Wochenschr; 1997 Feb; 122(7):177-81. PubMed ID: 9072487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolated perfusion of extremities for metastatic melanoma from an unknown primary lesion.
    Muchmore JH; Krementz ET; Carter RD; Sutherland CM; Mendoza EA
    South Med J; 1986 Mar; 79(3):288-90. PubMed ID: 3952537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of regional perfusion treatment on recurrent melanoma of the extremities.
    Hansson JA; Simert G; Vang J
    Acta Chir Scand; 1977; 143(1):33-9. PubMed ID: 855620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two methods of treating primary malignant melanomas Clark IV and V, thickness 1.5 mm and greater, localized on the extremities. Wide surgical excision with and without adjuvant regional perfusion.
    Martijn H; Schraffordt Koops H; Milton GW; Nap M; Oosterhuis JW; Shaw HM; Oldhoff J
    Cancer; 1986 May; 57(10):1923-30. PubMed ID: 3955499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation perfusion. An adjunct to surgical excision in the primary treatment of melanoma of the extremities.
    Alrich EM; Manwaring JL; Horsley JS
    Am J Surg; 1971 May; 121(5):583-5. PubMed ID: 5557770
    [No Abstract]   [Full Text] [Related]  

  • 39. Prophylactic hyperthermic limb perfusion in stage I melanoma.
    Krige JE; King HS; Strover RM
    Eur J Surg Oncol; 1988 Aug; 14(4):321-6. PubMed ID: 3044834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tourniquet infusion versus hyperthermic perfusion.
    Karakousis CP; Kanter PM; Park HC; Sharma SD; Moore R; Ewing JH
    Cancer; 1982 Mar; 49(5):850-8. PubMed ID: 7059923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.